Medgene collaborates with Elanco for H5N1 Cattle Vaccine
Shots:
- Medgene has entered into an agreement with Elanco to commercialize Medgene’s highly pathogenic avian influenza (HPAI/H5N1) vaccine in the US for dairy cattle
- Medgene's vaccine has met all USDA platform tech guidelines & is in final review for conditional approval, with manufacturing supply ready for deployment upon approval
- HPAI vaccine is developed using Medgene’s bioinformatics software
Ref: Elanco | Image: Elanco
Related News:- Elanco Animal Health Reports the US FDA’s Approval of Credelio Quattro for Protection Against Parasites in Dogs
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.co
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
